切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2018, Vol. 06 ›› Issue (02) : 124 -126. doi: 10.3877/cma.j.issn.2095-5782.2018.02.007

所属专题: 文献

专题研究·肿瘤介入

肝动脉化疗栓塞治疗肝细胞癌的应用现状与展望
何旭1, 占美晓1, 陆骊工1,()   
  1. 1. 519000 珠海市介入诊疗中心,珠海市人民医院(暨南大学附属珠海医院)
  • 收稿日期:2018-03-05 出版日期:2018-05-01
  • 通信作者: 陆骊工
  • 基金资助:
    国家自然科学基金面上项目(81571785、81771957)

Transcatheter arterial chemoembolization for hepatocellular carcinoma: Status and prospects

Xu He1, Meixiao Zhan1, Ligong Lu1()   

  • Received:2018-03-05 Published:2018-05-01
  • Corresponding author: Ligong Lu
引用本文:

何旭, 占美晓, 陆骊工. 肝动脉化疗栓塞治疗肝细胞癌的应用现状与展望[J]. 中华介入放射学电子杂志, 2018, 06(02): 124-126.

Xu He, Meixiao Zhan, Ligong Lu. Transcatheter arterial chemoembolization for hepatocellular carcinoma: Status and prospects[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2018, 06(02): 124-126.

[1]
中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范(2017年版)[J].临床肝胆病杂志,2017,33(8): 1419-1431.
[2]
王福安,眭未凡,吕朋华, 等.海藻酸钠微球联合肝动脉化疗栓塞治疗原发性肝癌的Meta分析[J/CD].中华介入放射学电子杂志, 2016, 4(4):192-196.
[3]
崔艳峰,祖茂衡,徐浩等.肝细胞癌TACE术后严重并发症分析[J].中国介入影像与治疗学,2005,2(1):31-33.
[4]
王卫东,黄巧胜,倪嘉延,等. TACE与索拉菲尼联合治疗中晚期肝癌临床研究的Meta分析[J].临床放射学杂志,2015,34(11): 1816-1821.
[5]
张磊,陆骊工,李勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,20(12): 968-973.
[6]
Chuan-Xing L, Xu H, Bao-Shan H, et al. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed[J]. Cancer Biol Ther, 2011, 12(10): 865-871.
[7]
Liapi E, Geschwind JF. Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization[J]. Cardiovasc Intervent Radiol, 2011, 34(1): 37-49.
[8]
Lencioni R, de Baere T, Burrel M, et al. Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations[J]. Cardiovasc Intervent Radiol, 2012, 35(5): 980-985.
[9]
Song DS, Choi JY, Yoo SH, et al. DC bead transarterial chemoembolization is effective in hepatocellular carcinoma refractory to conventional transarteral chemoembolization: A pilot study[J]. Gut Liver, 2013, 7(1): 89-95.
[10]
Kalva SP, Pectasides M, Liu R, et al. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma[J]. Cardiovasc Intervent Radiol, 2014, 37(2): 381-387.
[11]
Nie K, Shi L, Chen Q, et al. Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI[J]. Clin Cancer Res, 2016, 22(21): 5256-5264.
[12]
Liu Z, Zhang XY, Shi YJ, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J]. Clin Cancer Res, 2017, 23(23):7253-7262.
[13]
Wu J, Tha KK, Xing L, et al. Radiomics and radiogenomics for precision radiotherapy[J]. J Radiat Res, 2018, 59(suppl_1):i25-i31.
[14]
Rattay T, Symonds RP, Shokuhi S, et al. The Patient Perspective on Radiogenomics Testing for Breast Radiation Toxicity[J]. Clin Oncol(R Coll Radiol), 2018, 30(3): 151-157.
[15]
Qian K, Ma Y, Wan J, et al. The studies about doxorubicin-loaded p(N-isopropyl-acrylamide-co-butyl methylacrylate)temperature-sensitive nanogel dispersions on the application in TACE therapies for rabbit VX2 liver tumor[J]. J Control Release, 2015, 212:41-49.
[16]
Su Y, Wang K, Li Y, et al. Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy[J]. Nanomedicine(Lond), 2018 Apr 9. [Epub ahead of print]
No related articles found!
阅读次数
全文


摘要